The North America diabetes monitoring devices market is expanding with rising diabetes prevalence and stronger adoption of connected and wearable monitoring technologies. Continuous glucose monitoring and self-monitoring systems are gaining traction as consumers seek easier, more personalized ways to track glucose levels, while advanced healthcare infrastructure and digital health integration further support regional market development.

The Diabetes Monitoring Devices Market was valued at US$ 37.22 billion in 2025 and is projected to reach US$ 70.73 billion by 2034, expanding at a CAGR of 7.39% from 2026 to 2034.

Growing Demand for Diabetes Monitoring Technologies

Diabetes management requires continuous attention to blood glucose levels and appropriate treatment decisions. As the need for effective disease management increases, monitoring devices are becoming an important component of routine healthcare. The market includes blood glucose monitoring devices and insulin delivery devices, allowing patients and healthcare professionals to select technologies according to specific treatment and monitoring requirements.

Get Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00008454

Technological advancements are also changing how individuals monitor and manage diabetes. Smart devices, connected monitoring platforms, and digital health applications can support more convenient access to health information. The increasing emphasis on real-time glucose tracking is encouraging innovation in devices that can provide patients with actionable information and support more informed diabetes management.

Product Segmentation and Market Development

Based on product, the diabetes monitoring devices market is segmented into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring technologies remain essential for assessing glucose levels and supporting day-to-day disease management, while insulin delivery devices play an important role in administering insulin as part of diabetes treatment.

The development of increasingly integrated technologies is expected to strengthen demand across both categories. Manufacturers are focusing on improving convenience, usability, connectivity, and monitoring capabilities. Such developments are particularly relevant as patients seek solutions that can fit more easily into daily routines while healthcare providers increasingly value accessible patient data.

Increasing Adoption in Home Settings

By end user, the market covers hospitals, diagnostics, and home settings. Home-based diabetes monitoring is becoming increasingly important because it allows individuals to manage glucose levels outside conventional healthcare environments. Easy-to-use monitoring technologies can support routine measurement and encourage patients to participate more actively in their care.

At the same time, hospitals and diagnostic settings continue to require dependable monitoring technologies for patient assessment and clinical management. The combination of professional healthcare demand and increasing home use creates opportunities for manufacturers to develop devices that address different levels of user experience and healthcare requirements.

Smart Wearables and Real-Time Monitoring

Smart wearables are emerging as an important area of development in diabetes management. The integration of monitoring technologies with connected devices can provide more convenient access to health information and support real-time tracking. The Insight Partners identifies smart wearables for real-time monitoring as an important market opportunity, highlighting their potential to influence the evolution of diabetes care.

Affordable continuous glucose monitoring solutions also represent an opportunity for market participants. Wider availability of cost-effective technologies could support broader adoption among patients who require regular monitoring. In parallel, AI-driven insights can contribute to more personalized diabetes management by helping transform monitoring information into useful health-related insights.

AI, Digital Health, and Telehealth Integration

The combination of diabetes monitoring devices with digital health technologies is creating additional opportunities for market development. AI-powered applications can support personalized approaches to diabetes management, while connected platforms can facilitate the interpretation and sharing of monitoring information.

Telehealth is another emerging trend identified in the market. Greater use of remote healthcare services can improve access to diabetes support and enable patients to remain connected with healthcare professionals. These developments reinforce the importance of connected monitoring ecosystems rather than standalone devices.

Regional Market Landscape

The market is analyzed across North America, Europe, Asia-Pacific, South and Central America, and the Middle East and Africa, with country-level analysis covering major markets such as the US, Canada, Mexico, China, India, Japan, Australia, the UK, Germany, France, Brazil, Saudi Arabia, and the UAE.

The United States represents a key market within the global landscape. Market development in the country is associated with innovative diabetes technologies, smart devices for real-time glucose tracking, and evolving approaches to diabetes management. North America therefore remains an important region for technology adoption, product development, and competitive activity.

Leading Companies in the Diabetes Monitoring Devices Market

The competitive landscape includes established healthcare and medical technology companies developing and supplying diabetes monitoring and related technologies. Key players include:

• Abbott Laboratories
• ACON Laboratories, Inc.
• Ascensia Diabetes Care Holdings AG
• Becton, Dickinson and Company
• DexCom, Inc.
• F. Hoffmann-La Roche Ltd
• Johnson & Johnson
• Medtronic plc
• Novo Nordisk A/S
• Terumo Corporation

These companies contribute to market development through product innovation, technology advancement, and efforts to address changing requirements across hospitals, diagnostics, and home settings.

Future Outlook

The future outlook for the diabetes monitoring devices market remains promising as monitoring becomes increasingly connected, personalized, and accessible. Smart wearables are expected to play a greater role in real-time monitoring, while AI-powered applications may enable more individualized diabetes management. Telehealth can further expand access to diabetes support services, particularly by connecting patients with healthcare professionals remotely.

The availability of affordable continuous glucose monitoring technologies is another significant opportunity. As manufacturers continue to focus on usability, connectivity, and patient-centered innovation, the market is expected to evolve toward integrated diabetes management solutions. With the market projected to reach US$ 70.73 billion by 2034, continued technological advancement and growing demand for effective monitoring are likely to remain central to market development.

Related Reports @

Glucose Monitoring Devices Market Size and Competitive Analysis by 2030

Continuous Glucose Monitoring Device (CGMD) Market Drivers and Forecasts by 2031

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish